GSK Plc agreed on a partnership deal worth as much as $650 million with US biotech Vesalius Therapeutics to help advance drug ...

While generics may dominate due to cost advantages and meeting needs of a developing economy, there is a growing thrust ...

Deborah Waterhouse, CEO, ViiV Healthcare and president, global health, GSK, said: “At ViiV Healthcare we believe that everyone, no matter where they live, should have the freedom to be their authentic ...

Voxela, Inc. (Voxela), which created the AI care management system Voxela VCare, has completed its pre-Series A funding round. The company's proven track record of deployments in Japanese care ...

A higher incidence of asthma in South Africa is likely linked to high cases of bronchitis, according to the Clean Air Fund.

In addition, under our GSK collaboration, we recorded a non-cash reduction to ... Analysts planning to participate during the Q&A portion of the live call can join the conference call at the following ...

Medical experts have called for more health-care resources and education targeting women, children and the elderly during the ongoing China International Import Expo.There are 220 million children und ...

In a report released today, Peter Welford from Jefferies downgraded GlaxoSmithKline (GSK – Research Report) to a Hold, with a price ...

Jefferies analyst Peter Welford downgraded GSK (GSK) to Hold from Buy with a price target of $39.50, down from $53. The firm finds it “frustrating” that despite the favorable Zantac settlement, robust ...

GSK announced today that Health Canada has approved Ojjaara (momelotinib) for the treatment of splenomegaly and/or ...

BURLINGAME, Calif., November 12, 2024--(BUSINESS WIRE)--Innoviva, Inc. (NASDAQ: INVA) ("Innoviva" or the "Company"), a ...

The first payment of $25 million will be triggered if Royalty Pharma (RP) receives $240 million or more in royalty payments from GSK based on 2024 TRELEGY global net sales, which we expect would occur ...